Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
The Future Needs of External Beam Radiotherapy in Portugal Until 2040
E D Rodrigues1, P Almeida2, E López Ramírez3
1Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; CINTESIS - Center for Health Technology and Services Research/ RISE - Health Research Network, Porto, Portugal.
Portugal needs 18-30 new external beam radiotherapy (EBRT) machines by 2040 to meet rising cancer treatment demand. This investment is crucial for accessible, high-quality cancer care, requiring significant policy changes and funding.
Area of Science:
- Oncology
- Radiotherapy
- Health Economics
Background:
- External beam radiotherapy (EBRT) is vital for cancer treatment but faces global infrastructure and investment shortages.
- These deficits compromise cancer patient outcomes, highlighting the need for strategic planning.
Purpose of the Study:
- To quantify the future demand for EBRT in Portugal up to 2040.
- To estimate the required infrastructure and personnel to meet projected needs.
Main Methods:
- Utilized Global Cancer Observatory data for 2040 cancer case estimates in Portugal.
- Calculated optimal EBRT courses based on established guidelines (IAEA, ESTRO).
- Determined necessary EBRT machines (MV units) and staffing levels (radiation oncologists, medical physicists, therapists).
Main Results:
- Projected 18% increase in optimal EBRT courses by 2040, totaling approximately 34,000.
- Estimated need for 18-30 new EBRT machines/MV units.
- Required staffing includes 28-46 radiation oncologists, 22-36 medical physicists, and 61-102 radiation therapists.
Conclusions:
- Portugal faces a significant deficit in EBRT infrastructure.
- Addressing this requires policy reform and investment to ensure equitable access to radiotherapy.
Related Concept Videos
Biological Effects of Radiation
Absorption of Radiation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

